MORIA EVOLUTION 3 TURBINE CB 19303

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2010-04-09 for MORIA EVOLUTION 3 TURBINE CB 19303 manufactured by Moria.

Event Text Entries

[21319769] As a threshold matter, moria does not believe that these incidents were or are reportable, as the evolution 3 console device is not used directly on pts. Rather it is used to cut tissue from donor eyes for use in corneal transplants. If the tissue specimen is flawed in any way, the physician should not proceed with the transplant procedure. Therefore, there should be no risk to pts from an imperfect cut of donor tissue. It is unclear why the physician performed surgery with imperfect specimens in this case. That said, moria has conducted a thorough review and investigation of the medwatch reports filed by (b) (6) hospital, and hereby submits this response. This medical device report is written in response to two medwatch reports filed by (b) (6) hospital in (b) (6) (uf/importer report (b) (4)). Moria received copies of these reports on 04/03/2009. The reports state in both cases, the physician decided to continue with the procedure and implant the imperfectly-cut tissue into each pt's operative eye. According to (b) (6) hospital, both pts required a second dsaek procedure to replace the implanted corneal tissue with pre-cut, eye bank tissue and are now doing well. (b) (6) hospital returned turbine # (b) (4), the turbine involved in both incidents, to moria for eval. The hospital did not, however, save and return the microkeratome blade(s) used in the incidents. Moria's inspection of the equipment reveals that there was a microscopic imperfection in the threads on the back of the turbine, which led to an insecure connection between the turbine and the turbine hose, leading to a loss of power that adversely affected the quality of the corneal cut. Further eval of a "control" turbine hose confirmed that the threading imperfection was an issue only with the particular hose used in the two incidents, and is not a problem for other hoses tested on this machine. It is possible that damage to the threading occurred either during the shipping process or in the hospital facility. To moria's knowledge, the problem with the threading on the back of the loaner turbine, and (b) (6) hospital's experiences with the device, are isolated incidents that do not present quality control issues. Moria's eval also strongly suggests that (b) (6) hospital's use of the devices did not conform to published guidelines. As moria's evolution 3 instruction manual and (b) (4) user's manual state, users should check and confirm hose connectivity and proper power levels prior to use, which apparently was not done in these cases. The physician's decision to continue with surgery and implant donor corneal tissue in both pts-despite being aware that the cut was imperfect-is also notable.
Patient Sequence No: 1, Text Type: N, H10


[21365507] Two pts were affected -pts a and b.
Patient Sequence No: 1, Text Type: D, B5


[21553959] Two pts were affected -pts a and b.
Patient Sequence No: 2, Text Type: D, B5


[21695298] As a threshold matter, moria does not believe that these incidents were or are reportable, as the evolution 3 console device is not used directly on pts. Rather it is used to cut tissue from donor eyes for use in corneal transplants. If the tissue specimen is flawed in any way, the physician should not proceed with the transplant procedure. Therefore, there should be no risk to pts from an imperfect cut of donor tissue. It is unclear why the physician performed surgery with imperfect specimens in this case. That said, moria has conducted a thorough review and investigation of the medwatch reports filed by (b) (6) hospital, and hereby submits this response. This medical device report is written in response to two medwatch reports filed by (b) (6) hospital in (b) (6) (uf/importer report (b) (4)). Moria received copies of these reports on 04/03/2009. The reports state in both cases the physician decided to continue with the procedure and implant the imperfectly-cut tissue into each pt's operative eye. According to (b) (6) hospital, both pts required a second dsaek procedure to replace the implanted corneal tissue with pre-cut, eye bank tissue and are now doing well. (b) (6) hospital returned turbine #(b) (4), the turbine involved in both incidents, to moria for eval. The hospital did not, however, save and return the microkeratome blade(s) used in the incidents. Moria's inspection of the equipment reveals that there was a microscopic imperfection in the threads on the back of the turbine, which led to an insecure connection between the turbine and the turbine hose, leading to a loss of power that adversely affected the quality of the corneal cut. Further eval of a "control" turbine hose confirmed that the threading imperfection was an issue only with the particular hose used in the two incidents, and is not a problem for other hoses tested on this machine. It is possible that damage to the threading occurred either during the shipping process or in the hospital facility. To moria's knowledge, the problem with the threading on the back of the loaner turbine, and (b) (6) hospital's experiences with the device, are isolated incidents that do not present quality control issues. Moria's eval also strongly suggests that (b) (6) hospital's use of the devices did not conform to published guidelines. As moria's evolution 3 instruction manual and (b) (4) user's manual state, users should check and confirm hose connectivity and proper power levels prior to use, which apparently was not done in these cases. The physician's decision to continue with surgery and implant donor corneal tissue in both pts-despite being aware that the cut was imperfect-is also notable.
Patient Sequence No: 2, Text Type: N, H10


MAUDE Entry Details

Report Number2529598-2009-00002
MDR Report Key1655778
Report Source05,06
Date Received2010-04-09
Date of Report2009-05-01
Date of Event2009-03-11
Date Mfgr Received2009-03-20
Device Manufacturer Date2008-10-01
Date Added to Maude2010-04-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer Street1050 CROSS KEYS DR.
Manufacturer CityDOYLESTOWN PA 18902
Manufacturer CountryUS
Manufacturer Postal18902
Manufacturer Phone2152307662
Manufacturer G1MORIA FRANCE
Manufacturer Street#45P. L.P. EVOLIC 1
Manufacturer CityANTONY CEDEX 921B2
Manufacturer CountryFR
Manufacturer Postal Code921B2
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMORIA EVOLUTION 3 TURBINE
Generic NameNONE
Product CodeHMY
Date Received2010-04-09
Returned To Mfg2009-03-20
Model NumberCB
Catalog Number19303
Lot NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerMORIA
Manufacturer AddressANTONY FR


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2010-04-09
201. Other 2010-04-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.